Spots Global Cancer Trial Database for Molecular Markers of Chemosensitivity for Bladder Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Molecular Markers of Chemosensitivity for Bladder Cancer
Official Title: Molecular Markers of Chemosensitivity for Locally Advanced, Recurrent and Metastatic Bladder Cancer Based on the Adjuvant Chemotherapy of Gemcitabine and Cisplatin-a Prospective Control Study
Study ID: NCT02074241
Interventions
Study Description
Brief Summary: The purpose of this study is to try to figure out some bio-markers of chemosensitivity for adjuvant chemotherapy for bladder cancer.
Detailed Description: Figure out some bio-markers of chemosensitivity for adjuvant chemotherapy for bladder cancer.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Southwest hospital,Chian, Chongqing, Chongqing, China
Contact Details
Name: Zhiwen Chen, M.D,Ph.D
Affiliation: Southwest Hospital, China
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
